FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-4070
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2019
Authors
Publisher
American Association for Cancer Research (AACR)